Drugs / Alum
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06905275 Background | Jul 2025 → Jul 2027 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06905275 ↗ |
| Known as | Aluminum Hydroxide Suspension | “both adjuvanted with 3M-052-AF + Aluminum Hydroxide Suspension (Alum).” NCT06905275 ↗ |